This research reveals improved stereoselectivity and activity in an aldo-keto reductase mutant, suggesting effective detoxification of deoxynivalenol in food supplies.
The bioremediation strategy is a promising environmentally friendly alternative to eliminate deoxynivalenol (DON) contamination in feed and foodstuffs, but few direct and effective enzyme-catalyzed detoxification methods are currently available. Here, we identified an aldo-keto reductase with DON-degrading ability from the Devosia strain A6-243 (AKR6D2) through a stepwise gene mining approach. AKR6D2 was found to have great thermostability toward the reduction of C3 carbonyl oxygen of 3-keto- deoxynivalenol (3-keto-DON) but with poor stereoselectivity (44.97% e.e. for 3-epi- deoxynivalenol (3-epi-DON)), which limited its practical application. By reshaping the substrate-binding pocket of AKR6D2, a mutant W21A/G53N with excellent catalytic activity (330-fold higher) and stereoselectivity (>99% e.e. for 3-epi-DON) was obtained. Based on the insights provided by molecular dynamics simulations, W21A/G53N-3-keto-DONproR was more favorable in the formation of prereaction states to produce the R-configuration product. This work confirmed that engineered AKR6D2 is a powerful biocatalyst for the detoxification of DON in contaminated food and feed.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: